Please be aware that Mahajan Imaging & Labs will never request for your bank details or OTP for booking/registration purposes.

What is a AMINO LEVULINIC ACID (ALA) SPOT URINE?

The Amino Levulinic Acid (ALA) Spot Urine test measures the level of ALA, a substance involved in heme (hemoglobin) synthesis, in a single urine sample. Elevated ALA levels can indicate disorders such as porphyria, where heme production is disrupted, leading to symptoms like abdominal pain, neurological issues, or sensitivity to light. This test is used to help diagnose porphyrias and related metabolic conditions, offering a quick, non-invasive way to assess abnormalities in heme biosynthesis.

Additional Information

Also known as/ Other names: Spot Urine ALA Test, Urinary Aminolevulinic Acid – Spot Sample, ALA Urine Random Test, Random Urine Aminolevulinic Acid Test
Parameters: 1
Recommended for: M/F/Others
Sample Type: Random Urine
Patient Preparation: No prior preparation is needed
Reports: 2 days

FAQs

Why is this test done?

Healthcare professionals use it to diagnose porphyrias, metabolic conditions affecting hemoglobin production, and to investigate unexplained abdominal pain, neurological symptoms, or photosensitivity.

What conditions can this test detect?

It primarily helps identify porphyrias, disorders of heme biosynthesis, and related metabolic abnormalities.

Can medications affect the results?

Yes, certain drugs can alter heme metabolism and affect ALA levels. Inform your doctor about all medications.

What does a high level mean?

Elevated ALA suggests porphyria or impaired heme synthesis, often linked to enzyme deficiencies.

What does a low level mean?

Low levels are usually normal, but interpretation depends on symptoms and clinical context.

Can diet affect the results?

Diet usually has little effect, but certain triggers like alcohol may worsen porphyria symptoms.

Can dehydration influence the results?

Yes, dehydration can concentrate urine and affect ALA measurement.

How often is this test repeated?

It may be repeated to monitor disease progression or treatment response in porphyria patients.

Text copied to clipboard
Dynamic badges will be added here